Autor/es reacciones

Elena Élez

Oncologist at the Colon Cancer Unit of Vall d'Hebron Hospital.

This is a study that aims to answer a clinically relevant question in colon cancer, which is the reason why some tumors relapse even if they are surgically treated. It is also a solid research carried out by a consolidated group.  

The results of this research could form the basis for developing prospective clinical trials aimed at answering this hypothesis [that immunotherapy before surgery would improve prognosis], which must be confirmed before being implemented in clinical practice.  

The main limitation is that this is preclinical work. It assumes a basis, but it is still very incipient for its applicability.

EN